Recent news on Xyrem

Deputies investigating theft, resale of pills  -  May 17, 2007
Bainbridge Post Searchlight,...the anesthetic ketamine, a preparation of GHB known as Xyrem, a synthetic form of THC known as Marinol, intermediate-acting barbiturates and others.

Jazz Pharmaceuticals provides information on its latest news and ...  -  Apr 12, 2007
Therapeutics Daily (subscription) (press release),Report 1: Jazz Pharmaceuticals, Inc., announced the signing of an agreement licensing Canadian marketing rights for Xyrem (sodium oxybate) to Valeant

International Approvals: Symbicort SMART, Alimta, Xyrem  -  Mar 19, 2007
Medscape (subscription)On March 12, the European Commission (EC) approved a new indication for sodium oxybate oral solution (Xyrem, Jazz Pharmaceuticals, Inc, and marketed by UCB

New European Approval for Xyrem(R) Provides Significant Advance in ...  -  Mar 13, 2007
PipelineReview.com (press release),This new indication means that Xyrem(R) is the first and only European Commission-approved medicine for this indication and supports the European Federation

New European Approval For Xyrem® Provides Significant Advance In ...  -  Mar 12, 2007
Medical News Today (press release),The European Commission has approved Xyrem® (sodium oxybate) for the treatment of narcolepsy with cataplexy in adult patients. This new indication means

UCB gets new European approval for Xyrem  -  Mar 14, 2007
Pharma Times (subscription),Belgium's UCB says that it has received the go-ahead in Europe for a new indication of its narcolepsy treatment Xyrem. The European Commission has approved

UCB says received new EU approval for narcolepsy drug Xyrem  -  Mar 12, 2007
ForexTV.com,BRUSSELS (AFX) - Pharmaceuticals group UCB SA said the European Commission has approved Xyrem for the treatment of narcolepsy with cataplexy in adult

Investigators Zero In on Pill Pushing Doctors  -  Mar 14, 2007
Lawyers and Settlements,In one speech quoted in the indictment, he told doctors that "table salt is more dangerous," than Xyrem, and the FBI likened him to a "carnival snake-oil

Pet cemetery?  -  Mar 9, 2007
Austin American-Statesman (subscription),Without a label, it’s hard to discern what the medication is. Xyrem is a controlled substance prescribed for patients with weak or paralyzed muscles.

Enel, Heineken, Swisscom, Telefonica: European Equity Preview  -  Mar 13, 2007
BloombergUCB SA (UCB BB): The Belgian drugmaker that bought Germany's Schwarz Pharma AG said the European Commission approved Xyrem for the treatment of narcolepsy

Brussels shares close lower on weak Wall Street opening UPDATE  -  Mar 13, 2007
Forbes,The pharmaceuticals group announced yesterday that the European Commission's drug evaluation agency has approved its Xyrem drug for the treatment of

Brussels shares marginally down in midmorning trade; financials fall  -  Mar 13, 2007
Forbes,UCB was up 0.28 eur or 0.59 pct at 47.90 after the pharmaceuticals group said the European Commission's drug evaluation agency has approved its Xyrem drug

UCB Full-Year 2006 Financial Results  -  Feb 28, 2007
PharmaLive.com (press release),...selling expenses in Japan following Zyrtec®‘s new co-distribution agreements as well as new product launches such as Equasym™ XL and Xyrem® in Europe.

European Medicines Agency Adopts Positive Opinion Recommending ...  -  Jan 27, 2007
Medical News Today (press release),Troy Cox, President CNS Operations, UCB said, 'This positive opinion is encouraging news and we now look forward to the opportunity of making Xyrem®

Valeant Pharmaceuticals signs licensing pact for Canadian rights ...  -  Feb 8, 2007
Therapeutics Daily (subscription) (press release),Xyrem, a liquid formulation of sodium oxybate, is the first product approved in Canada to treat cataplexy, which is a sudden loss of muscle tone associated

Mum wins drugs battle  -  Feb 7, 2007
Sheffield Today,Wendy got in touch with The Star at the end of last year when she was offered hope that new drug Xyrem, which costs £9000-a-year, could help her condition

Valeant Pharmaceuticals Signs Licensing Agreement for Canadian ...  -  18 Jan 2007
PharmaLive.com (press release),..."Xyrem is a strategic fit for our existing marketing and sales organizations in Canada and we are excited about the potential of this agreement and the

Jazz, Valeant in marketing deal for cataplexy drug  -  18 Jan 2007
Charlotte Business Journal,...loss of muscle tone associated with narcolepsy. Valeant expects to launch and distribute Xyrem in Canada in mid 2007 through its neurology sales force.

Friday's Health Winners & Losers  -  18 Jan 2007
TheStreet.comXyrem should be available to patients there in mid-2007. AstraZeneca's (AZN - commentary - Cramer's Take) shares gained 2.6% to $56.49 after Bear Stearns

Valeant licenses rights to Jazz's Xyrem  -  Jan 12, 2007
United Press International12 (UPI) -- Valeant said Friday it licensed Canadian rights to Jazz's cataplexy treatment Xyrem for an undisclosed amount. Under the terms of the deal,

Jazz Pharmaceuticals Signs Licensing Agreement With Valeant ...  -  Jan 12, 2007
CNW Telbec (Communiqués de presse),The agreement calls for Valeant to make an upfront payment to Jazz Pharmaceuticals and to make payments based on future Xyrem sales in Canada.

Deal Wakes Up Valeant  -  Jan 12, 2007
TheStreet.comValeant Pharmaceuticals' (VRX - commentary - Cramer's Take) shares rose 2.4% after it announced a partnership with Jazz Pharmaceuticals involving its Xyrem

EXECUTIVE SUMMARY  -  Jan 12, 2007
Orange County Business Journal,The deal calls for Valeant to make an undisclosed upfront payment to Jazz and future payments based on Canadian sales of Xyrem. Valeant said in a release

Market Report -- In Play (VRX)  -  Jan 12, 2007
MSN MoneyValeant Pharmaceuticals sgns licensing agreement for Canadian rights to Xyrem from Jazz Pharmaceuticals Co announced that it has signed a licensing

(PRN) - Canadian Class Action Commenced by Owners of Dell Inspiron ...  -  Jan 12, 2007
Bolsamania.com,...(PRN) - Jazz Pharmaceuticals Signs Licensing Agreement With Valeant Pharmaceuticals for Canadian Marketing Rights to Xyrem(R) ... [+]

'Wake-up' call to health chiefs over sleep woe  -  Jan 3, 2007
Sheffield Today,After years of unsuccessful treatment, Wendy was recommended for the drug Xyrem, which trials have shown can help sufferers to better manage their condition

Sleep disorder mum gets drugs go-ahead  -  Jan 8, 2007
Sheffield Today,Her hospital consultant had recommended a new medication, Xyrem, which offered hope of improving her quality of life. But Wendy thought she would not be

Loving grandma avoids collapse by becoming 'bit of a cold fish'  -  Jan 5, 2007
Yorkshire Post Today,A drug, sodium oxybate, or Xyrem, has now been licensed to treat it but so far she has been unable to persuade her health care trust to fund it.

Gran ill if she says 'I love you'  -  Jan 4, 2007
The Sun,Xyrem is licensed in Britain but her local trust says it cannot afford it. Wendy said: “There is no cure but it could control the attacks.�

Woman paralysed by saying I love you  -  Jan 4, 2007
Metro,The drug, marketed as Xyrem, has just been licensed in Britain after trials in the US but her local healthcare trust refuses to pay the £9000 a year it

The mother who faints if she says: I love you  -  Jan 4, 2007
Daily Mail,Mrs Richmond is fighting to be prescribed sodium oxybate, or Xyrem, on the Health Service. The new drug has been licensed in the EU for help in controlling

Drug Linked to Abuse Used for Good  -  Dec 14, 2006
WIBW,The new medication is sold under the name Xyrem. Its active ingredient is GHB. Tthose who work with sleep patients are happy to see Xyrem on the market.

Sedative Hypnotics  -  Dec 6, 2006
Focus (subscription)It is marketed under the trade name Xyrem and is available under a tightly controlled distribution system. Sodium oxybate is a potent sedative agent,

Foro de Shell Security - Seguridad informática  Oct 27, 2006
...normal Bc xopenex ll lymphoid follicular structures, are generally l xylocaine ss aggressive than lymphomas that proliferate in a diffuse p xyrem ttern. ... -Shell Security, Volunteers Needed for Stanford Study of Potential Alternative to ...  Oct 17, 2006
The study will compare the sleeping pill zoldipem tartrate, marketed as Ambien, with the narcolepsy drug sodium oxybate, marketed as Xyrem. ... -PharmaLive.com (press release), Jazz Pharmaceuticals Announces Phase III Clinical Trial to Study ...  Sep 8, 2006
Jazz Pharmaceuticals announced today the initiation of a Phase III clinical trial intended to evaluate the safety and efficacy of Xyrem® (sodium oxybate) oral ... -PipelineReview.com

Sedative Hypnotics  -  Dec 6, 2006
Focus (subscription)It is marketed under the trade name Xyrem and is available under a tightly controlled distribution system. Sodium oxybate is a potent sedative agent,

Military objective: less sleep, more fight  -  Nov 23, 2006
Houston Chronicle,One of them, Xyrem, produced by Jazz Pharmaceuticals, has been approved by the Food and Drug Administration for the treatment of narcolepsy. Army Maj. Gen.

INDICTMENT OF DOCTOR TESTS DRUG MARKETING RULES  22 Jul 2006
Dr. Gleason acknowledges that he received more than $100,000 last year alone from Jazz Pharmaceuticals, which makes Xyrem, the narcolepsy drug he has promoted. ... -Amherst Times.com

New medicines for narcolepsy  Jul 11, 2006
...control sleepiness. Provigil is one such medicine. Xyrem is a drug that specifically targets cataplexy attacks. The Narcolepsy and ... -Sarasota Herald-Tribune

Narcolepsy is more than just uncontrollable urge to sleep  Jul 10, 2006
...control sleepiness. Provigil is one such medicine. Xyrem is a drug whose specific target is cataplexy attacks. It's a restricted ... -SouthCoastToday.com



Coach mum on reports he was drugged  Apr 20, 2006
Jazz Pharmaceuticals, of Palo Alto, Calif., manufactures GHB under the trade name Xyrem for the treatment of patients with narcolepsy, a sleep disorder. ... - The Athens News





Jazz launches Xyrem for new narcolepsy indication  Mar 7, 2006
By Staff Writer. Jazz Pharmaceuticals has launched Xyrem oral solution in the US, for patients with narcolepsy who suffer from excessive daytime sleepiness. ... - Pharmaceutical Business Review

Date-rape drug indictment  Apr 6, 2006
Mauskopf, charges that Thomas Gleason, who lives in Maryland, participated in a nationwide scheme to illegally promote the prescription drug Xyrem to physicians ... - Newsday



Study Finds That Xyrem(R) (Sodium Oxybate) Relieves Pain in ...  Feb 23, 2006
23 /PRNewswire/ -- Patients with fibromyalgia syndrome taking Xyrem(R) (sodium oxybate) in a Phase II clinical trial experienced significant pain relief ... - PR Newswire,

Xyrem Helps Fibromyalgia Pain -- Study  Feb 23, 2006
The drug Xyrem (sodium oxybate) shows promise in relieving pain in patients with a chronic condition called fibromyalgia. An eight ... - International News Service,

Sodium Oxybate May Reduce Fibromyalgia Pain: Presented at AAPM  Feb 24, 2006
...title: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-Center Trial Comparing the Effects of Orally Administered Xyrem (Sodium Oxybate ... - DG News

Anderson Angels  Feb 16, 2006
...able to move.". Angel Flights flew Heeter to and from St. Louis for an FDA study of a new drug called Xyrem. Without their help, Heeter ... - NewsLink Indiana,

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional